This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

PSS Profits From Niches: Under the Radar

JACKSONVILLE, Fla. (TheStreet) -- PSS World Medical (PSSI) supplies equipment and drugs to doctors' offices, long-term care facilities and home-care providers. The company's non-hospital focus has helped it generate consistent growth.

The Jacksonville, Fla.-based company's fiscal first-quarter net income rose 42% to $13 million and earnings per share climbed 53% to 23 cents, boosted by a lower share count. Revenue grew 5% to $494 million. Its gross margin rose from 29% to 30%, but its operating margin remained steady at 4%.

PSS's elder care unit is benefitting as the aging baby boomer generation boost demand for medical treatment. Its quarterly sales jumped 7% and its operating margin tacked on 85 basis points. The company's physician supply unit posted 3% sales growth and a 169 basis point improvement in operating margin.

The company has a stable financial position. PSS holds $130 million of cash, translating to an adequate quick ratio of 1.5. A debt-to-equity of 0.6 reflects conservative leverage. We give the company a financial strength score of 7.9 out of 10, higher than the "buy"-list average of 7.

With a trailing price-to-earnings ratio of 21 and a forward price-to-earnings ratio of 18, the stock trades at a premium to the market and other medical suppliers. However, the premium is justified by a record of consistent growth. PSS has achieved a three-year average growth rate of 6% for revenue and 13% for profit.

Shares of PSS have advanced 28% in the past year, outperforming the 6.1% increase of the S&P 600 Health Care Index. The stock has climbed 17% annually, on average, in the past five years, compared with a 6.4% gain for the benchmark. PSS has a beta, a measure of market correlation, of 0.8 and doesn't pay dividends.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,086.63 -26.91 -0.16%
S&P 500 1,987.01 +3.48 0.18%
NASDAQ 4,473.6970 +17.6810 0.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs